Clinical and genetic features in a MELAS child with a 3271T>C mutation

Hsiao-Feng Chou1, Wen-Chen Liang, Qing Zhang

  • 1Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.

Pediatric Neurology
|January 22, 2008
PubMed

Insights

The mitochondrial DNA 3271T>C mutation causes MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes). Urinary sediments show high mutation loads, offering a non-invasive diagnostic option.

Area of Science:

  • Genetics
  • Mitochondrial Diseases
  • Neurology

Background:

  • The mitochondrial DNA 3271T>C point mutation is a significant cause of MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes), particularly in Japan.
  • This mutation is infrequently reported globally, making its prevalence and diagnostic markers in diverse populations less understood.

Observation:

  • An 11-year-old Taiwanese girl presented with MELAS symptoms including short stature, continuous focal epilepsy, stroke-like episodes, intellectual decline, speech difficulties, and gait disturbance.
  • Analysis of various tissues revealed high proportions of the 3271T>C mutant mitochondrial DNA, with muscle tissue near 100% mutant load.

Findings:

  • Urinary sediments exhibited the highest mutation load among non-muscle tissues in the patient, detected by both PCR-RFLP and quantitative real-time PCR.
  • This study is the first to utilize quantitative real-time PCR for mutant load analysis of the 3271T>C mutation, confirming the utility of urinary sediments.

Implications:

  • Urinary sediments represent a promising, non-invasive alternative tissue for diagnosing mitochondrial DNA 3271T>C mutations.
  • This finding could simplify diagnostic procedures for MELAS and other mitochondrial disorders caused by this specific mutation.